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Background: Stoma site incisional hernias after ileostomy closure are complex hernias 
that can be associated with abdominal pain, discomfort, and a diminished quality of life. 
The aim of this study was to determine the incidence of incisional hernia (IH) following 
temporary ileostomy reversal in patients undergoing colorectal surgery, and the risk 
factors associated with its development. 
 
Methods: This was an observational study of patients undergoing ileostomy reversal 
between January 2010 and December 2016. Comorbidities, operative characteristics and 
postoperative complications were analysed. Bivariable and multivariable analyses were 
used to assess IH incidence and risk factors. 
 
Results: A total of 202 consecutive patients were prospectively evaluated 
(median follow-up 46 months; range: 12 - 109). Stoma site incisional hernia occurred in 
23% of patients (n=47). The reasons for the primary surgery were colorectal cancer (n= 
141, 69.8%), inflammatory bowel disease (n=14, 6.9%), emergency surgery (n=35, 
17.3%), and other conditions (n=12, 5.9%). Statistically significant risk factors for 
developing an IH were obesity (higher BMI) (OR 1.15, 95% CI (1.05 – 1.26)). Other 
comorbidities such as diabetes, immunosuppression, and anaemia, as well as surgical 
technique variables, surgical wound infection and other post-surgical complications were 
not predictive of hernia. 
 
Conclusions: 23% of patients developed surgical site IH, a higher BMI being the only 
risk factor found to be statistically significant in the development of an incisional hernia. 
 





Temporary ileostomies can be carried out when high-risk colorectal anastomosis are 
performed, to minimise the symptoms of a potential anastomotic leak. These ileostomies 
can also be performed in patients with ulcerative colitis after a panproctocolectomy to 
avoid sepsis related to the ileo-anal pouch, or as emergency surgery to treat actual 
anastomotic leaks, among other reasons [1-3]. 
 
The morbidity associated with ileostomy closure is 14% to 31% [4-7]. The possible 
complications include incisional hernia (IH), surgical wound infection, small bowel 
obstruction, and anastomotic leaks. These complications may counteract the possible 
benefits of a protective ileostomy. 
 
The incidence of stoma site IH after an ileostomy closure reported in the scientific 
literature varies between 5% and 23.9% [8-13]. The risk factors for these complications 
are: a higher body mass index (BMI) [8-10,12]; high blood pressure [8,11]; a previous 
history of IH [8-10]; and surgical factors, such as open surgery [10]. 
 
The goal of this study is to determine the incidence of IH after an ileostomy closure 
related to colorectal surgery. The secondary objective is to determine the incidence of a 
midline IH, and to describe any risk factors associated with developing surgical site IH. 
 
Material and Methods 
 
This was a prospective observational study: all of the patients included underwent an 
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ileostomy closure between January 2010 and December 2016 in a University Hospital in 
Madrid, Spain. Patients who had an ileostomy in other hospitals and those who had a 
follow-up of less than one year were excluded. 
 
We included demographic variables, such as age, gender, and smoking habit; the reason 
for the primary operation within which the ileostomy was performed, for example, for 
rectal cancer, inflammatory bowel disease, emergency surgery, or other reasons (familial 
adenomatous polyposis, oncologic gynaecological surgery, etc.); any comorbidities and 
the basal health status, including BMI, diabetes, immunosuppression, chronic obstructive 
pulmonary disease (COPD), connective tissue diseases, and anaemia. Other variables 
analysed were the presence/absence of previous surgeries; the ASA classification; the 
surgical technique and any postoperative complications, such as postoperative emergency 
surgery or surgical site infection, according to the Clavien Dindo classification. In 
patients with rectal cancer, we also included variables related to their disease, such as 
stage, presence of metastasis on diagnosis, and the presence of adjuvant or neoadjuvant 
treatment. 
 
Definition of surgical site incisional hernia 
We defined IH according to the criteria of the European Hernia Society, in other words, 
any abdominal wall gap with or without a bulge in the area of a postoperative scar 
perceptible or palpable by clinical examination or imaging [14]. 
 
Surgical Technique 
The ileostomy closures were performed under general anaesthesia by a colorectal surgeon 
or by a supervised general surgery resident. Prophylactic antibiotic was administered in 
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every case. The surgery was initiated with a mucocutaneous disinsertion and a circular 
incision, as close as possible to the edge of the ileostomy. Patients with a terminal 
ileostomy also required a median laparotomy. After performing adhesiolysis, stoma 
resection and manual or mechanical latero-lateral anastomosis followed. Fascia closure 
was performed using slow absorbing 0 or 1 monofilament in 96.5% of patients, and a fast 
absorbing multifilament in 7/202 patients (3.5%). Skin closure was performed using a 
purse-string suture, leaving no drainage. 
 
Follow-up 
Patient follow-up data was obtained from the evaluations carried out in the general 
surgery medical offices, and from the reports on additional diagnostic procedures. 
 
From a radiology perspective, a CT scan was performed on oncology patients, such as 
those with rectal cancer and gynaecological tumours. The scans were ordered following 
the protocols at our hospital: at least two CT scans during the first two years, the first 
between six months and one year after surgery, and the second between the first and the 
second year. In non-oncological patients, if no CT scan was performed during follow-up 
and there were doubts in physical examination, an abdominal wall sonography during a 
Valsalva manoeuvre was performed to assess a possible incisional hernia. 
 
Statistical analysis 
The statistics were calculated using the Statistical Package for the Social Sciences 
(SPSS), v.21.0 for Windows (IBM Corp. Released 2012. IBM SPSS Statistics for 
Windows, Version 21.0. Armonk, NY: IBM Corp). Quantitative variables were described 
as means and standard deviations in normal distributions, or as medians and ranges in the 
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event of a non-normal distribution. Qualitative variables were expressed in 
percentages. The Pearson's Chi-Square test was used to compare the qualitative variables; 
for quantitative variables that met the necessary conditions, the Student’s T-test was used; 
the Mann-Whitney and Wilcoxon U-test was used for non-parametric correlations. A 
multivariate analysis was considered with a binary logistical regression, showing the odds 
ratio (OR) for predictor variables. 
 




Over the period analysed, a consecutive sample of 284 subjects were given a temporary 
ileostomy after colorectal surgery. However, 82 patients did not meet the inclusion 
criteria, meaning the final sample comprised 202 patients (Fig. 1). Their mean age was 
61.81 years (±13 years) and 127 were male (62.9%). They had an average body mass 
index (BMI) of 25.7 kg/m2 (±3.82 kg/m2), 13.4% were smokers, and 9.9% were diabetic. 
The demographic variables, basal health status, comorbidities, and the statistical analysis, 
is shown in Table 1. 
 
The original surgeries, which were the reason for the temporary ileostomy, were: 
colorectal cancer (n=141, 69.8%); emergency surgery (n=35, 17.3%); inflammatory 
bowel disease (n=14, 6.9%); and other surgeries (n=12, 5.9%). Open surgery was 
performed in 80% of cases, while a laparoscopic approach was selected in the remaining 
20%. A lateral ileostomy was performed on 195 patients (96.5%), and a terminal 
ileostomy on 7 patients (3.5%). Early ileostomy closure (less than 21 days after the initial 
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surgery) was undertaken in 46% of cases, with the average being 14 days after the initial 
surgery. Delayed ileostomy closure was performed in the other 54% of cases, at a mean 
of 199 days after the initial surgery. 
 
The median follow-up was 46 months (range: 12 – 109). The postoperative and follow-
up variables, as well as the statistical analysis, are described in Table 2. 
 
Clinical and radiological evaluation of the abdominal wall 
Stoma surgical site IH after an ileostomy closure was diagnosed in 23% of patients. The 
IH was clinically diagnosed in 24/47 patients (51%) and radiologically diagnosed with a 
CT scan in 41/44 patients (93.1%). (Table 3) (Fig. 2) 
 
Our series of patients, in which we also analyse the midline IH, shows an incidence of 
46% (n=93), both abdominal wall defects being present in 12.8% of patients (n=26). The 
presence of a midline IH was not a risk factor for developing a stoma site IH (p=0.145). 
During follow-up, the abdominal wall was surgically repaired in 29.8% of patients with 
a stoma site IH. 
 
Risk factors for developing an IH after ileostomy closure surgery 
The different demographic variables, basal health status, and comorbidities were 
analysed. These variables included gender, age, diabetes, COPD, anaemia, smoking, ASA 
classification, and obesity (Table 1). The only variable identified as a risk factor, both in 
the bivariable and multivariable analyses, was a higher BMI. 
 
A multivariate analysis of the predictor variables (those with a univariate p value of 
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<0.150; risk of suffering diabetes, age, BMI, and a midline incisional hernia) was run to 
determine the risk of stoma site incisional hernia. This was performed using a conditional 
back-step model, and only BMI was significant with an OR of 1.15 (IC95%:1.05-1.26; 
p=0.003). 
 
The original surgery, during which the ileostomy was performed, had no influence on the 
development of IH. Thus, colorectal cancer, inflammatory bowel disease and emergency 
surgery were not identified as risk factors (p=0.152). 
 
For patients with colorectal cancer, stage, neoadjuvant and adjuvant treatments were not 
identified as risk factors for developing IH after the stoma closure (Table 4). 
 
Another interesting result was that surgical wound infection was present in 27% of 
patients (n=55), but had no statistical significance as a risk factor for IH (p=0.231). 
 
Surgical time was also analysed. For patients who developed an IH the average surgical 
time was 72 minutes (± 30 minutes), while for those that did not develop an IH the average 
time was 70 minutes (±27). There was no statistically significant difference between the 
groups (p=0.66). 
 
Lastly, neither the time lapse between the first surgery and the ileostomy closure nor the 






IH can be associated with abdominal pain, discomfort, a worse quality of life, and 
emergency surgery due to incarceration or strangulation of abdominal content [15,16]. 
Stoma site IH after an ileostomy closure is a complex hernia and usually associated with 
IH in other locations. Surgical technique is key in lowering the IH rate. 
 
In our data set, 23% of patients who underwent an ileostomy closure after colorectal 
surgery developed a surgical site IH; similar results are found in the literature, with an 
incidence ranging between 5% and 23.9% [8-13]. Unlike in other studies, we did not 
include IH secondary to colostomy closures, since we do not consider the two groups to 
be comparable. For example, the incidence of IH is described as being much higher in the 
latter, up to 48% [17,18]. One reason for this disparity could be the need for a larger 
fascial defect when performing the initial colostomy. 
 
The bivariable and multivariable analyses identified only one variable as a statistically 
significant risk factor for developing a surgical site IH: a higher BMI. In a literature 
review, studies analysing the risk factors for surgical site IH after an ileostomy closure 
describe the risk factors as being a higher BMI [8,10-12], high blood pressure [8,11] and 
a previous history of IH [8,10]; surgical factors have also been identified as risk factors, 
such as open surgery when the ileostomy was performed, being younger, and delayed 
ileostomy closure [10]. 
 
In our series there were no statistically significant differences in the rate of surgical site 
IH when comparing open and laparoscopic surgery. Keersmaecker et al. [13] reached the 
same conclusion, although the study performed by Mishra et al. [19] showed a higher rate 
of IH with laparoscopic surgery. Since in many studies surgical wound infection has been 
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described as a risk factor for IH, various skin closure techniques have also been analysed 
[20]. Our group performs a purse-string closure, which showed a 27% incidence of 
surgical wound infection and did not significantly impact the incidence of IH (p=0.231). 
 
One factor that we included has never before been analysed, which was our hypothesis 
for supporting early ileostomy closure: the time lapse between performing the ileostomy 
and its closure. We hypothesised that a longer time would lead to a higher incidence of 
IH due to more altered dynamics of the abdominal wall forces. However, our study 
revealed that this duration is not a risk factor in developing an IH; the comparison of early 
(<21 days) and delayed (>21 days) ileostomy closures did not significantly influence the 
development of an IH (p=0.90). The same result was seen when a stratified analysis was 
made over several time periods (p=0.52). 
 
We consider that many studies underdiagnose their IH rate, for both the midline and 
ileostomy closure, since they do not include imaging techniques in their follow-up. In our 
case, 51% patients with IH were diagnosed clinically, whereas when a CT scan was 
included in the follow-up, the diagnosis rose to 93.1% of patients. This latter percentage 
could have been even higher if the imaging had included a dynamic sequence, with the 
patient making a Valsalva manoeuvre. In addition, performing an abdominal ultrasound 
during a physical exploration could increase sensitivity for diagnosing an IH [21]. 
 
As we have already mentioned, IH can be symptomatic and may develop complications. 
For this reason, surgical treatment may be indicated to repair this defect, a procedure 
which might be necessary in up to 64% of patients [22]. In our series, approximately one 
in three patients (29.8%) required an eventroplasty. Our favoured technique involved 
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placing a mesh in the retromuscular space. 
 
It is interesting to note that, in our series, no stoma site IH after ileostomy closure occurred 
in patients with inflammatory bowel disease. Our explanation for this is that these patients 
underwent scheduled non-emergency surgeries, and that the patients were younger and 
had a lower BMI than the other patients. 
 
There is still no consensus on the use of a prophylactic mesh during ileostomy closure to 
lower the prevalence of IH, and only a few studies describe its use. Liu et al. [23] 
presented a case-control study with 83 patients. They placed a preaponeurotic 
polypropylene mesh and had a lower incidence of IH, dropping from 36.1% to 6.4% (OR 
8.29, p=0.001), with no significant statistical differences in surgical wound infection 
between the two groups. Warren et al. [24] made a retrospective review of their patients 
with a polypropylene preperitoneal mesh; they do not describe any IH in ileostomy 
closure patients, but with no statistical significance, and there were also no differences in 
infection rate. Maggiori et al. [25] presented a blind prospective case-control study, in 
which a prophylactic porcine biological mesh was placed in the retromuscular space after 
ileostomy closure in 30 patients. No short-term statistically significant differences were 
found, including infection rates; although, a long-term CT-scan control during follow-up 
found significantly lower rates of IH (3% versus 19%, p=0.043). 
 
Although these are very satisfactory results, more studies are needed to support the use 
of the mesh, as well as a consensus on the material used and where to place this. 
 
The limitations of our study are those inherent to any descriptive study. The moment of 
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IH diagnosis is not recorded, so this work is not useful for determining how long it takes 
an IH to develop. Another limitation is the lack of a CT control scan for some patients.  
 
In conclusion, in our series, 23% of patients developed a surgical site IH, a higher BMI 
being the only risk factor that was found to be statistically significant in the development 
of an incisional hernia. 
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Table 1. Demographic variables, basal health status and comorbidities. 
 
 
  Hernia No hernia 
p 
 (N=47) (N=155) 
Age, mean(sd) 64.5 (9.95) 60.3 (13.8) 0.054 
Gender       
     Male, n (%) 29 (61.7) 98 (63.2) 
0.85 
     Female, n (%) 18 (38.3) 57 (36.8) 
Initial surgery       
     Rectal cancer, n (%) 35 (74.5) 106 (68.4) 
0.152 
     IBD, n (%) 0 (0.0) 14 (9.0) 
     Emergency surgery, n 
(%) 
10 (21.3) 25 (16.1) 
     Others, n (%) 2 (4.3) 10 (6.5) 
Diabetes 8 (17.0) 14 (9.0) 0.124 
Immunosuppresion 1 (2.1) 2 (1.3) 0.678 
COPD 3 (6.4) 7 (4.5) 0.605 
ACE inhibitor 10 (21.3) 33 (21.3) 0.998 
Conectivopathy 0 (0.0) 2 (1.3) 0.434 
Previous laparotomy 11 (23.4) 37 (23.9) 0.678 
Smoking habit 4 (8.5) 23 (14.8) 0.365 
Hemoglobin, mean (sd) 13.0 (1.96) 13.2 (1.99) 0.574 
Anemia (Hb < 12 g/dl) 15 (31.9) 43 (27.7) 0.580 





ASA classification       
     I, n (%) 2 (4.3) 9 (5.8) 0.590 
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     II, n (%) 27 (57.4) 95 (61.3) 
     III, n (%) 16 (34.0) 49 (31.6) 
     IV, n (%) 2 (4.3) 2 (1.3) 
*Statistical significance (p<0.05) 
COPD: chronic obstructive pulmonary disease; ACE: angiotensin-converting-enzyme; 










































Table 2. Patient operative & follow-up data 
 
 
  Hernia No hernia 
P 
 (N=47) (N=155) 
Follow-up  
     1-2 years, n (%) 9 (19.1) 25 (16.1) 
0.488 
     2-3 years, n (%) 6 (12.8) 33 (25.3) 
     3-4 years, n (%) 11 (23.4) 26 (16.8) 
     >4 years, n (%) 21 (44.7) 71 (45.8) 
Ileostomy closure   
     Early, n (%) 22 (46.8) 71 (45.8) 
0.904      Delayed, n (%) 25 (53.2) 84 (54.2) 
Days to ileostomy closure  
0.480 
     <20 days, n (%) 22 (44.4) 71 (45.8) 
     20-50 days, n (%) 0 (0.0) 2 (1.3) 
     51-100 days, n (%) 4 (8.5) 6 (3.9) 
     101-200 days, n (%) 9 (19.1) 42 (27.1) 
     >200 days, n (%) 12 (25.5) 35 (22.6) 
Surgical technique  
0.898      Laparotomy, n (%) 38 (80.9) 124 (80.0) 
     Laparoscopy, n (%) 9 (19.1) 31 (20.0) 
Resurgery 4 (8.5) 5 (3.2) 0.124 
Midline incisional hernia 26 (55.3) 67 (43.2) 0.145 
Abdominal wall repair 
surgery 
14 (29.8) 20 (12.3) 0.007 
Stoma closure infection 16 (34.0) 39 (25.2) 0.231 
Post-operative complication  0.173 
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     No, n (%) 38 (80.9) 139 (89.7) 
     Paralytic ileus, n (%) 5 (10.6) 10 (6.5) 
     Anstomotic leak, n (%) 3 (6.4) 6 (3.9) 





     I, n (%) 20 (42.6) 79 (51.0) 
     II, n (%) 22 (46.8) 70 (45.2) 
     IIIA, n (%) 1 (2.1) 0 (0.0) 
     IIIB, n (%) 3 (6.4) 5 (3.2) 
     IVA, n (%) 1 (2.1) 1 (0.6) 
 


































Table 3. Patients with incisional hernia 
 
 
  Physical examination CT Scan 
Total Hernias 
 (N =202) (N=183) 
Stoma site incisional hernia 24/47 (51.1%) 41/44 (93.1%) 47/202 (23%) 








































Table 4. Risk factors for incisional hernia in colorectal cancer surgery 
 
 
  Hernia No hernia 
p 
 (N =35) (N=106) 
Stage** 
      
     I, n (%) 
11 (37.9) 25 (30.9) 
0.212 
     II, n (%) 
6 (20.7) 21 (25.9) 
     III, n (%) 
7 (24.1) 30 (37.0) 
     IV, n (%) 
5 (17.2) 5 (6.2) 
Diagnosed metastasis** 
5 (14.3) 5 (4.7) 0.056 
Neoadjuvant 
treatment** 
25 (71.4) 79 (74.5) 0.718 
Chemotherapy** 
15 (42.9) 38 (35.8) 0.458 


















284 patients were 
operated performing a 
temporary ileostomy
202 patients eligible for 
inclusion
47 patients (23%) with  
stoma site incisional 
hernia
155 patients without 
stoma site incisional 
hernia
Excluded: 82 patients
Follow-up < one year: 78
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